Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Two patients (8.7%) showed decreased vitamin D levels.

Source: Vitamin Levels. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were divided into three groups: Group A: patients with DSO, Group B: patients with osteomyelitis and medication‐related osteonecrosis, and Group C: healthy control group.

Source: Abstract.

This prospective cohort study was approved by the institutional review board of the University Hospital of Munich, Germany (Munich, Germany; UE Nr 23‐0285).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

New Insights Into Diffuse Sclerosing Osteomyelitis: Is There a Role of ANA and Vitamin B6?

Cohort study · Oral Diseases · 2025

Original publication title

New Insights Into Diffuse Sclerosing Osteomyelitis: Is There a Role of ANA and Vitamin B6?

Katharina Theresa Obermeier; Tim Hildebrandt; Ina Dewenter; Wenko Smolka; Eric Hesse; Philipp Poxleitner; Sven Otto

© 2025 The Author(s). Oral Diseases published by John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Elevated ANA titers and elevated vitamin B6 levels provide a possible insight into the pathomechanisms of DSO. Therefore, in the search for the pathogenesis and etiology of DSO, autoimmune processes should also be considered.

An extract from the source publication. Read it in context.

At a glance

Abstract: What methods does the paper describe?

In this prospective study, blood samples were collected from a total of 25 patients and analyzed to detect altered laboratory values to have insight into possible pathomechanism. Patients were divided into three groups: Group A: patients with DSO, Group B: patients with osteomyelitis and medication‐related osteonecrosis, and Group C: healthy control group.

Source: Subjects and Methods

Abstract: Object

Diffuse sclerosing osteomyelitis is a poorly understood chronic disease, which appears predominantly in the mandible. Female patients are more often affected than men. DSO is an ultra‐rare disease and incidence is unknown; diagnosis can be very challenging; pathogenesis is poorly understood.

Source: Object

Abstract: Results

44% of all patients in group A had elevated Vitamin B6 levels. Compared to groups B and C, these levels were statistically significantly higher (p = 0.011, p = 0.015). 23 patients had increased (92%) antinuclear‐antibody‐titer (ANA‐Titer); in group B, 52% of all patients, and in the healthy control group, 44%.

Source: Results

Abstract: Conclusions

Elevated ANA titers and elevated vitamin B6 levels provide a possible insight into the pathomechanisms of DSO. Therefore, in the search for the pathogenesis and etiology of DSO, autoimmune processes should also be considered.

Source: Conclusions
Authors’ abstract

ABSTRACT

Object

Diffuse sclerosing osteomyelitis is a poorly understood chronic disease, which appears predominantly in the mandible. Female patients are more often affected than men. DSO is an ultra‐rare disease and incidence is unknown; diagnosis can be very challenging; pathogenesis is poorly understood.

Subjects and Methods

In this prospective study, blood samples were collected from a total of 25 patients and analyzed to detect altered laboratory values to have insight into possible pathomechanism. Patients were divided into three groups: Group A: patients with DSO, Group B: patients with osteomyelitis and medication‐related osteonecrosis, and Group C: healthy control group.

Results

44% of all patients in group A had elevated Vitamin B6 levels. Compared to groups B and C, these levels were statistically significantly higher (p = 0.011, p = 0.015). 23 patients had increased (92%) antinuclear‐antibody‐titer (ANA‐Titer); in group B, 52% of all patients, and in the healthy control group, 44%.

Conclusions

Elevated ANA titers and elevated vitamin B6 levels provide a possible insight into the pathomechanisms of DSO. Therefore, in the search for the pathogenesis and etiology of DSO, autoimmune processes should also be considered.

Publication and source details

Original title: New Insights Into Diffuse Sclerosing Osteomyelitis: Is There a Role of ANA and Vitamin B6?

Katharina Theresa Obermeier; Tim Hildebrandt; Ina Dewenter; Wenko Smolka; Eric Hesse; Philipp Poxleitner; Sven Otto

Oral Diseases · 2025

* Correspondence:
Katharina Theresa Obermeier (katharina.obermeier@med.uni-muenchen.de)
© 2025 The Author(s). Oral Diseases published by John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T03:37:34.250620+00:00

DOI: 10.1111/odi.70028 · PMC13364960